Dynamic Quality Control Strategy for Lab Results

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Diagnostic devices often produce test results with inherent imprecision and systematic errors, leading to incorrect patient results, which can cause harm if not detected in time, and existing quality control strategies for immediate release of results are impractical due to increased costs and reduced patient specimen testing capacity.

Innovation Solution

A quality control strategy that analyzes patient risk by calculating the probability and severity of harm using reference samples, adjusting the interval between QC events and the number of reference samples tested, to minimize incorrect results and balance resource allocation for quality control and patient specimen testing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If the interval between QC events is decreased or the number of reference samples is increased, then the reliability of test results is improved, but the productivity and cost efficiency deteriorate

Engineering Contradiction:
Improvereliability of test resultsVSAvoidpatient specimen testing capacity
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The QC strategy dynamically adjusts the interval between QC events and the number of reference samples based on real-time assessment of instrument performance and patient risk factors. When instrument stability is high and patient risk is low, QC frequency is reduced to maximize productivity. When instability is detected or patient risk increases, QC frequency automatically increases to maintain reliability, resolving the contradiction between continuous monitoring and operational efficiency.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system changes QC parameters (interval between events, number of reference samples) based on assessed conditions. By calculating patient harm probability and instrument reliability metrics, the system selectively intensifies QC only when and where needed, rather than applying uniform frequent QC to all situations. This parameter adaptation maintains reliability while optimizing overall productivity and resource allocation.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If more reference samples are tested at each QC event, then the measurement precision of QC assessment is improved, but the loss of time and reduced productivity occur

Engineering Contradiction:
Improveprecision of QC assessmentVSAvoidtime for QC events
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system applies partial QC action by testing only the necessary number of reference samples at each QC event based on assessed needs. Instead of always testing the maximum number of samples, the system calculates the minimum required samples to achieve adequate measurement precision for the current patient risk level and instrument performance, thereby reducing time loss while maintaining sufficient QC assessment precision.

Inventive Principle:
Principle #16Partial or excessive action

3Reliability

If QC events are performed frequently to detect systematic errors, then the reliability of patient results is improved, but the cost and resource consumption increase

Engineering Contradiction:
Improvedetection of systematic errorsVSAvoidcost of QC strategy
Core Design Contradiction:
ReliabilityVSLoss of energy

Solution Approach 1:

The system uses feedback from previous QC events, instrument performance data, and patient risk assessments to determine the optimal frequency and intensity of subsequent QC events. This feedback loop allows the system to maintain high reliability for error detection while avoiding unnecessary QC events that would waste resources. The feedback mechanism ensures QC is performed at the minimum frequency needed to maintain safety, optimizing the balance between reliability and cost.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS11579155B2Using patient risk in analysis of quality control strategy for lab results
Publication Date: 2023.02.14 BIO RAD LABORATORIES INC
  • US11579155B2 patent drawing
  • US11579155B2 patent drawing
  • US11579155B2 patent drawing

AI summary

Methods, apparatuses, and systems are disclosed for analyzing quality control (QC) strategies that are applied to testing processes an analyte in order to meet an acceptable level of probability of patient harm that could result from incorrect test results. The measure of patient harm takes into account severity of patient harm, as well as its occurrence. Methods include calculating, based on the parameters of the QC strategies and the test apparatus, an expected number of incorrect final results E(Nuf) due to a test system failure. The value of E(Nuf) can be used as part of a calculation of a predicted level of probability patient harm. The ratio of the acceptable level of probability of patient harm to the predicted level of probability patient harm can determine the adequacy of the QC strategies.